Akıl, Mehmet AtaAcet, HalitElbey, Mehmet AliAydın, MesutBilik, ZihniYıldız, AbdülkadirÜlgen, Sıddık2020-04-302020-04-3020140393-6384https://hdl.handle.net/20.500.12684/4244Yuksel, Murat/0000-0003-2636-5211WOS: 000364114800011Aim: To investigate the predisposing factors, demographic and clinical characteristics, echocardiographic and prognostic features, and Outcomes of patients with native valve infective endocarditis (IE) in Turkey in a multicenter based study. Materials and methods: The study population consisted Of 15,8 consecutive patients with native valve IE (NVE). Data on demographics, medical history, medications, clinical procedures, predisposing factors, clinical examination, microbiology, antibiotic therapy, echocardiography, surgery, complications, and outcome were collected and compared. Results: The mean age of the patients was 47 19 (range 13-87). Seventy seven patients (49%) Were female. Of the 158. NVE patients, 49 died during hospitalization. Mortality rate was 31%. Twenty eight patients experienced a stroke. The patients who died during hospitalization were significantly older than the survivors and had higher mean heart rate, white blood cell, C reactive protein, creatinine, poor NYHA functional etas's, multiple vegetations and large vegetations. Culture negative endocarditis was seen in 54 eases (34%). Staphylococci were the most common causative organisms (28%). Eighty patients had undergone surgical treatment (51%). Hemoglobin, presence of multiple vegetation, vegetation size. (>10 mm), septic shock and poor NYHA Class on admission were independent risks for in hospital mortality and stroke Beside these variables C. reactive Protein was also an independent risk for in hospital mortality Conclusion: Native valve IE in Turkey was associated with high in hospital mortality. Rheumatic heart disease continues to be the most common underlying heart condition and echocardiographie findings on admission were the most important independent predictors of mortality or stroke.eninfo:eu-repo/semantics/closedAccessnative valve endocarditiprognostic factorsmortalityArticle30510351039WOS:000364114800011N/AQ4